Web View
Japan grows for a third straight quarter, but its companies still won't spend
Japan's economy grew again in the June quarter on household spending and exports, while companies kept their wallets shut; elsewhere, Seven & i's ¥300bn alliance money finally lands and Kakaku.com's suitor sweetens its bid for a second time.
MARKETS
Market pulse
Tokyo equities softened while the 10Y JGB yield nudged higher.
Sourced from Nikkei, JPX, BOJ, MOF - values, not commentary.
lead
Japan's Economy Grows Again, Companies Still Won't Spend

Japan's economy grew 0.5% in the June quarter, but companies flinched on investment
Japan's economy grew for a third straight quarter, expanding 0.5% on the previous quarter in the three months to June 2026, an annualized 1.9%, according to the Cabinet Office's first preliminary GDP estimate. Households kept spending and exports outran imports, while businesses pulled back: capital expenditure fell 1% in the quarter even as the headline number improved.
What changed: Consumption and net exports carried growth this quarter; corporate investment moved in the opposite direction, falling 1%.
Why it matters: A third consecutive quarter of expansion is a real data point for an economy that has spent years worrying about demand, but a corporate sector still unwilling to spend on plant and equipment means the growth rests on households and exporters rather than broader business confidence.
What to watch: Whether capital expenditure recovers in the Cabinet Office's next GDP revision, or keeps dragging on an otherwise positive quarter.
secondary
Big Ticket Moves

Seven & i Completes ¥300.0bn Share Placement to SoftBank, PayPay and Mitsui Sumitomo Card
Seven & i Holdings confirmed on August 17 that SoftBank Corp., PayPay Corporation and Mitsui Sumitomo Card Co. have completed payment for the third-party allotment of treasury shares the retailer's board approved on July 31. The three companies paid ¥2,070 a share for 144.9mn shares, converting the alliance announced three weeks earlier into a completed ¥300.0bn capital injection.
Why it matters: A board resolution is an intention; a payment-completion notice is money that has actually changed hands, tying SoftBank, PayPay and Mitsui Sumitomo Card's payment and telecom networks more closely to Japan's largest convenience-store operator.

Kakaku.com Buyout Price Rises for a Second Time, to ¥3,570, as Key Holders Stay Out of the Tender
Kamgras 1 KK has raised its tender offer for Kakaku.com to ¥3,570 a share, the second increase since the ¥3,000 opener in May, and pushed the deadline to August 27, extending the offer period to 75 business days. Kakaku.com's own corrected opinion on the bid confirms the same terms. Digital Garage, which holds 20.64% of Kakaku.com, and KDDI, which holds 17.67%, are declining to tender. Digital Garage plans instead to reinvest part of its proceeds into a stake of about 20% in the buyout vehicle's parent once the company goes private and squeezes out remaining holders.
Why it matters: A second price increase in three months signals holdout pressure on the buyout consortium, while the two disclosed shareholders choosing a post-squeeze-out buyback over tendering shows a preference for staying economically exposed to Kakaku.com's future.
Sumitomo Mitsui Trust Sets Terms for a ¥40bn Bond That Can Be Wiped to Zero
Sumitomo Mitsui Trust Group has filled in the terms on its 25th series of ten-year unsecured subordinated bonds, an amended shelf registration filed August 17 that replaces a July 24 filing which had simply marked the terms "undetermined." The filing indicates an initial coupon of 2.400% to 3.200%, with a later reset spread of 0.250% to 1.050% over the five-year JGB yield.
The catch: Holders would lose their entire principal, not just deferred interest, if regulators ever declared the trust bank group failing, a loss-absorption feature built into the instrument.
Why it matters: The pricing gives fixed-income investors a fresh benchmark for Japanese bank Tier 2 paper as trust banks compete to fill capital buffers.
Mitsui Chemicals Closes Ultradent Deal a Month Early, Shifts Oral-Care Command to the US
Faster regulatory approvals let Mitsui Chemicals finish buying Ultradent Products a month ahead of plan on August 14, and the company is relocating global headquarters functions for its oral-care business from Japan to the new US holding company, with the earnings impact still under review.
OKI Locks In 60% Stake as It Carves Out Its ATM Business Into a Hitachi Joint Venture
Oki Electric will transfer its ATM and automated-equipment business into Hitachi Channel Solutions for newly issued shares plus a cash-funded top-up, reaching a 60% stake from October 1, 2026, while the profit impact for the year after next stays under review.
secondary
Governance Watch

Advance Create's Restated Books Show a ¥6.1bn Hole in Shareholders' Equity
Advance Create's corrected first-quarter filing for the year ending September 2025 shows liabilities now exceed assets by ¥6.1bn, with net assets at negative ¥6.11bn against total assets of just ¥6.17bn, an equity ratio of -99.1%. The correction also discloses a breach of covenants tied to receivables-securitization contracts, and the company's auditor has flagged material doubt about its ability to keep operating.
What to watch: Advance Create has said it is considering calling an extraordinary shareholders' meeting, planned within three months of the May 2 record date, as part of addressing the capital shortfall.

Charon Finance Lifts Iwaki Stake to 18.95%, Reserves Right to Push on Board and Payouts
The Swiss investor's holding in Tokyo Stock Exchange Prime-listed Iwaki jumped from 16.96% to 18.95% on August 7, and its own filing reserves the right to seek board changes, higher dividends and share buybacks.
secondary
Policy Watch

Japan Drafts Order to Lift Farm Loan Cap to ¥200mn and Widen Loan Eligibility
MAFF has opened a three-week comment window, closing September 6, on a Cabinet Order that would raise the individual borrower cap on Agricultural Modernization Loans from ¥18mn to ¥200mn, lengthen the maximum repayment term to 20 years, and add a specified agricultural-sector financial institution to the list of owners that let a farm-support company qualify for the loans, ahead of an October 1 effective date tied to the underlying law.
quick hits
Quick Hits
Takashimaya's July Duty-Free Sales Jump 26%, Then Cool Sharply in August
Read moreTax-free sales at Takashimaya jumped 26.2% in July on pricier tourist purchases, but the retailer's own August tally already shows visitor transaction counts falling even as average spending keeps rising.
Iyotetsu Group Crosses 10% Stake in Shikoku Electric Power
Read moreIyotetsu Group, the Ehime transport conglomerate, borrowed ¥8.35bn from Aozora Bank and Nomura Trust and Banking as part of a ¥27.81bn total outlay that lifted its Shikoku Electric Power stake to 10.17%, still filed as pure investment with no stated board or governance ambitions.
Nomura's Nikkei 300 ETF Trades Nearly 8% Below Its Own Net Asset Value
Read moreNomura Asset Management's Nikkei 300 exchange-traded fund (ticker 1319) traded as much as 7.87% below its net asset value over seven consecutive sessions through August 14, and the manager attributes the gap to market supply and demand conditions.
Sanden Sells Its Gunma Factory for ¥8.0bn, Then Rents It Straight Back
Read moreSanden is selling its Gunma manufacturing complex to Industrial & Infrastructure Fund for ¥8.0bn, nearly double book value, and booking a roughly ¥3.3bn gain while signing a 15-year leaseback to keep the plant running.
Oasis Management Lifts Infomart Stake to 10.94%, Says It Has Already Proposed Asset Sales
Read moreOasis Management's stake in Infomart climbed to 10.94% from 9.74% on ¥13.48bn of buying, and its filing shows the fund has already proposed asset sales while reserving the right to push for a new chief executive, board changes or delisting within the next year.
SymBio's ¥6.77bn EVO Fund Deal Could More Than Double Its Share Count
Read moreSymBio Pharmaceuticals lined up an estimated ¥6.77bn from Cayman fund EVO Fund to keep its antiviral drug trials funded through March 2028, but the bond-and-warrant structure could swell its share count by more than 125% if every warrant is exercised.
PowerX Draws ¥7.0bn Syndicated Loan to Refinance ¥6.0bn of Existing Debt
Read morePowerX drew ¥7.0bn from an ¥8.0bn Mizuho-led syndicated facility to repay ¥6.0bn of existing borrowing, with the new loan due back on September 17 and secured against company real estate and receivables.
Mitsubishi Corp. Sells Its Entire 20% Stake in Toyo Tire Back to the Company
Read moreA 30.82 million-share block, a fifth of Toyo Tire's stock, moved off-market from Mitsubishi Corporation back to the tire maker itself at ¥3,602 a share, an EDINET filing shows, with no stated reason attached.
A One-Off Building Sale Is Doing the Heavy Lifting in Nippon Building Fund's 26% Profit Jump
Read moreA ¥5.2bn gain from selling one Tokyo building drove most of Nippon Building Fund's 26.2% profit rise; core leasing profit grew only 2.1%, and management now guides for two straight periods of lower earnings before a partial recovery in mid-2027.